KRAS IN-44
Product Specifications
Target
PDE|||PI3K|||Akt|||Apoptosis|||Ras|||mTOR
Related Pathways
Cytoskeletal Signaling|||MAPK|||PI3K/Akt/mTOR signaling|||Metabolism|||Apoptosis
Bioactivity
KRAS IN-44 (Compound S2C2M2) is a PDE6D degrader. It inhibits PDE6D-dependent KRAS transport and downstream signaling pathways. Additionally, KRAS IN-44 downregulates EGF-induced phosphorylation of PI3K, AKT, and mTOR. It promotes apoptosis and exhibits antitumor activity against hepatoblastoma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Netrin-G1a Antibody (1010035) [DyLight 650]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
130159-HRP 100 µL
NAT2 (Arylamine N-acetyltransferase 2, Arylamide Acetylase 2, N-acetyltransferase Type 2, NAT-2, Polymorphic Arylamine N-acetyltransferase, PNAT, AAC2) (HRP)
Ask
View Details 